Evidence map›Paper›PMID 17446996›Full record

ReviewJournal of neurology2007

The neuralgic amyotrophy consultation.

Nens van Alfen

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of neurology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 134 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. A case report of neuralgic amyotrophy.Frontiers in neurology · 2024
    Article
  8. IncreasedBMC neurology · 2023
    Article
  9. Review
  10. Article
  11. Parsonage-Turner syndrome after COVID-19 infection.JSES reviews, reports, and techniques · 2022
    Article
  12. Bilateral neuralgic amyotrophy in a patient with livestock-associated hepatitis E virus infection.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2022
    Article
  13. Article
  14. Article
  15. Neuralgic amyotrophy: an underrecognized entity.The Journal of international medical research · 2021
    Article
  16. Neuralgic Amyotrophy: Its Importance in Orthopedics Practice.Spine surgery and related research · 2021
    Review
  17. Clinico-diagnostic features of neuralgic amyotrophy in childhood.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Nens van AlfenNeurologist, clinical neurophysiologist, Neuromuscular Centre Nijmegen, Dept. of Neurology and Clinical Neurophysiology, c/o 920 KNF, Radboud University Nijmegen, Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. n.vanalfen@neuro.umcn.nl
Radboud University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuralgic amyotrophy is a distinct clinical syndrome with acute severe pain and patchy paresis in the shoulder and arm region. The clinical phenotype was recently found to be more comprehensive and the long-term prognosis less optimistic than usually assumed for many patients. The disorder can be idiopathic or hereditary in an autosomal dominant fashion, with only few phenotypical variations between the two. This article provides a practical overview of current knowledge on the clinical presentation, diagnosis, pathogenesis and the treatment of pain and complications.

Indexed as

Brachial PlexusBrachial Plexus NeuritisDiagnosis, DifferentialHumansMuscle, SkeletalMuscle WeaknessNeuralgiaShoulderShoulder Joint

Identifiers

PMID17446996
PMCPMC2780663
OpenAlexW2154738455

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.